Latest News and Press Releases
Want to stay updated on the latest news?
-
AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion Acquisition delivers AstraZeneca biologics ambition...
-
Cheshire, UK -- (MARKET WIRE) -- January 3, 2007 --Not for release, publication or distribution, in whole or in part, in, into or from the United States, Canada, Australia and Japan ...
-
Application has been made to the Financial Services Authority in its capacity as competent authority under the Financial Services and Markets Act 2000 (the "UK Listing Authority") for debt instruments...
-
-
CONTENTS General information Report of the supervisory board 2 Report of the management board 5 Financial statements...
-
CHICAGO, Ill., July 20, 2004 (PRIMEZONE) -- PI (Physicians Interactive), a leader in the e-Detailing industry which it helped pioneer, is set to launch a series of new initiatives that will further...
-
CHICAGO, Ill., July 20, 2004 (PRIMEZONE) -- PI (Physicians Interactive), a leader in the e-Detailing industry which it helped pioneer, is set to launch a series of new initiatives that will further...
-
Slough, U.K., May 18, 2004 (PRIMEZONE) -- Celltech Group plc -- Celltech's shareholders to receive 550 pence per ordinary share (equivalent to USD 19.44 per American ...
-
London, UK, March 22, 2004 (PRIMEZONE) -- AstraZeneca Does Not Recommend or Endorse Unsolicited "Mini-Tender" Offer AstraZeneca PLC announced today that it has...
-
UPPSALA, Sweden, August 19, 2003 (PRIMEZONE) -- 454 Life Sciences Obtains Exclusive License from Pyrosequencing AB (Other OTC:PYRSF) to Next Generation Sequencing Technology for Whole Genome...